Thus, the GFRAL- and hepatic triglyceride-dependent tissue-protective effect (68) could also support the survival of neoplastic tissue when attacked by an immune response and thereby change the delicate balance between tumor and immune cells. The gene discussed is GFRAL; the disease is neoplasm.